Abstract
The pathobiology of CF lung disease has yet to be fully elucidated and several theories have been proposed in recent years relating the basic biochemical defect caused by CFTR dysfunction to the CF phenotype. Within the last decade accumulating evidence has suggested that the pulmonary inflammation observed in CF patients may be intrinsically related to the CFTR mutation, resulting in an augmented inflammatory response. This review discusses our changing understanding of the link between CFTR dysfunction and CF lung disease, focusing especially on the role of hyperinflammatory processes. A better understanding of these mechanisms will lead to better treatments for CF and other suppurative lung diseases.
Keywords: Cystic fibrosis, inflammation, CFTR, Pseudomonas aeruginosa
Current Respiratory Medicine Reviews
Title: Inflammation, Hyperinflammation & Cystic Fibrosis Lung Disease – A Paradigm Shift?
Volume: 5 Issue: 3
Author(s): Emmet H. Major and J. Stuart Elborn
Affiliation:
Keywords: Cystic fibrosis, inflammation, CFTR, Pseudomonas aeruginosa
Abstract: The pathobiology of CF lung disease has yet to be fully elucidated and several theories have been proposed in recent years relating the basic biochemical defect caused by CFTR dysfunction to the CF phenotype. Within the last decade accumulating evidence has suggested that the pulmonary inflammation observed in CF patients may be intrinsically related to the CFTR mutation, resulting in an augmented inflammatory response. This review discusses our changing understanding of the link between CFTR dysfunction and CF lung disease, focusing especially on the role of hyperinflammatory processes. A better understanding of these mechanisms will lead to better treatments for CF and other suppurative lung diseases.
Export Options
About this article
Cite this article as:
Major H. Emmet and Elborn Stuart J., Inflammation, Hyperinflammation & Cystic Fibrosis Lung Disease – A Paradigm Shift?, Current Respiratory Medicine Reviews 2009; 5 (3) . https://dx.doi.org/10.2174/157339809788922388
DOI https://dx.doi.org/10.2174/157339809788922388 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Structural Analysis of Relevant Drug Targets for Alzheimer's Disease: Novel Approaches to Drug Development
Current Bioactive Compounds Anticancer Potential of Dietary Natural Products: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors
Inflammation & Allergy - Drug Targets (Discontinued) Challenges in Managing Amniotic Fluid Embolism: An Up-to-Date Perspective on Diagnostic Testing with Focus on Novel Biomarkers and Avenues for Future Research
Current Pharmaceutical Biotechnology Anti-Inflammatory and Pro-Resolving Effects of N-3 PUFA in Cancers: Structures and Mechanisms
Current Topics in Medicinal Chemistry The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
CNS & Neurological Disorders - Drug Targets Modulation of the Rho/ROCK Pathway in Heart and Lung after Thorax Irradiation Reveals Targets to Improve Normal Tissue Toxicity
Current Drug Targets Bridging the Gap Between Chemistry and Biotechnology - Large Molecules with Potential, How Could Biotechnology Complement Chemistry?
Current Organic Chemistry Prodrugs to Codrugs
Current Drug Therapy Recent Developments of Thalidomide Derivatives Possessing Anti-Inflammatory Activity
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Molecular Functions of Nod Proteins and their Associated Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Indole-3-Carbinol (I3C) and its Major Derivatives: Their Pharmacokinetics and Important Roles in Hepatic Protection
Current Drug Metabolism Genetic and Molecular Factors in Drug-Induced Liver Injury: A Review
Current Drug Safety Tumor Necrosis Factor Inhibitors in Pediatric Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Immunomodulatory Lactoferrin in the Regulation of Apoptosis Modulatory Proteins in Cancer
Protein & Peptide Letters Chemokine Receptors as Specific Anti-Inflammatory Targets in Peripheral Nerves
Endocrine, Metabolic & Immune Disorders - Drug Targets Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Biomarker for Non – Acute Kidney Injury (AKI) Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Therapeutic Potential, Synthesis, Patent Evaluation and SAR Studies of Thieno[3,2-d]pyrimidine Derivatives: Recent Updates
Current Drug Targets Potential Applications of Bacterial Cellulose in Environmental and Pharmaceutical Sectors
Current Pharmaceutical Design Surgery for Severe Obesity: Indications, Techniques, Mechanisms of Weight Loss and Diabetes Resolution
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)